Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?
Jun Liong Chin, Michael Pavlides, Ahmad Moolla, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management
Thomas Marjot, Ahmad Moolla, Jeremy Cobbold, et al.
Endocrine Reviews (2019) Vol. 41, Iss. 1, pp. 66-117
Open Access | Times Cited: 190
Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study
Mary E. Rinella, Jean‐François Dufour, Quentin M. Anstee, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 3, pp. 536-548
Open Access | Times Cited: 118
Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults
Christopher D. Byrne, Janisha Patel, Eleonora Scorletti, et al.
BMJ (2018), pp. k2734-k2734
Open Access | Times Cited: 101
Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection
Pathik Parikh, John Ryan, Emmanuel Tsochatzis
Annals of Translational Medicine (2017) Vol. 5, Iss. 3, pp. 40-40
Open Access | Times Cited: 95
Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies
Koen C. van Son, L.C. te Nijenhuis-Noort, Sebastiaan C. Boone, et al.
Medicine (2024) Vol. 103, Iss. 1, pp. e34934-e34934
Open Access | Times Cited: 13
Hepatic iron is the major determinant of serum ferritin in NAFLD patients
John Ryan, Andrew E. Armitage, Jeremy Cobbold, et al.
Liver International (2017) Vol. 38, Iss. 1, pp. 164-173
Open Access | Times Cited: 83
Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
Anshika Jangra, Ashish Kothari, Phulen Sarma, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1500-1500
Open Access | Times Cited: 31
An activatable near-infrared molecular reporter for fluoro-photoacoustic imaging of liver fibrosis
Minqian Miao, Jia Miao, Yuan Zhang, et al.
Biosensors and Bioelectronics (2023) Vol. 235, pp. 115399-115399
Closed Access | Times Cited: 16
von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C
Hiroaki Takaya, Hideto Kawaratani, Yuki Tsuji, et al.
United European Gastroenterology Journal (2018) Vol. 6, Iss. 9, pp. 1401-1409
Open Access | Times Cited: 38
Multiparametric MR mapping in clinical decision-making for diffuse liver disease
Helena Thomaides‐Brears, Rita Lepe, Rajarshi Banerjee, et al.
Abdominal Radiology (2020) Vol. 45, Iss. 11, pp. 3507-3522
Open Access | Times Cited: 36
Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi
Ian Baudi, Takako Inoue, Yasuhito Tanaka
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 949-949
Open Access | Times Cited: 32
Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings
Uday Kumar Marri, Prasenjit Das, S. Shalimar, et al.
Radiology (2021) Vol. 298, Iss. 3, pp. 600-608
Closed Access | Times Cited: 30
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease
Tyng‐Yuan Jang, Chi‐Chang Ho, Po‐Cheng Liang, et al.
The Kaohsiung Journal of Medical Sciences (2023) Vol. 40, Iss. 3, pp. 304-314
Open Access | Times Cited: 10
Combination Therapy of Endoscopic Gastric Remodeling with GLP-1RA for the Treatment of MASLD
Pichamol Jirapinyo, Aunchalee Jaroenlapnopparat, Stephen D. Zucker, et al.
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1471-1478
Closed Access | Times Cited: 3
Screening for hepatocellular carcinoma: patient selection and perspectives
Waleed Fateen, Stephen Ryder
Journal of Hepatocellular Carcinoma (2017) Vol. Volume 4, pp. 71-79
Open Access | Times Cited: 38
Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging
Shen Pan, Xiaoqi Wang, Qiyong Guo
World Journal of Gastroenterology (2018) Vol. 24, Iss. 18, pp. 2024-2035
Open Access | Times Cited: 34
Vibration‐controlled transient elastography for the detection of cirrhosis in chronic hepatitis D infection
Ben L. Da, Pallavi Surana, Varun Takyar, et al.
Journal of Viral Hepatitis (2019) Vol. 27, Iss. 4, pp. 428-436
Open Access | Times Cited: 31
Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver “Triple Screen”
Gavin Low, Craig Ferguson, Stephanie Locas, et al.
Abdominal Radiology (2023) Vol. 48, Iss. 6, pp. 2060-2073
Closed Access | Times Cited: 9
Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA
Karn Wijarnpreecha, Charat Thongprayoon, Melissa Scribani, et al.
European Journal of Gastroenterology & Hepatology (2017) Vol. 30, Iss. 4, pp. 404-410
Closed Access | Times Cited: 30
Pirfenidone alleviates concanavalin A-induced liver fibrosis in mice
Mostafa M. Salah, Ahmed A. Ashour, Tamer M. Abdelghany, et al.
Life Sciences (2019) Vol. 239, pp. 116982-116982
Closed Access | Times Cited: 29
Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD
Santo Colosimo, Hamish Miller, Dimitrios A. Koutoukidis, et al.
Diabetes Research and Clinical Practice (2024) Vol. 217, pp. 111820-111820
Closed Access | Times Cited: 2
Clinic-radiological features and radiomics signatures based on Gd-BOPTA-enhanced MRI for predicting advanced liver fibrosis
Wanjing Zheng, Wei Guo, Meilian Xiong, et al.
European Radiology (2022) Vol. 33, Iss. 1, pp. 633-644
Closed Access | Times Cited: 12
Combining 99mTc-GSA single-photon emission-computed tomography and Gd-EOB-DTPA-enhanced magnetic resonance imaging for staging liver fibrosis
Ryotaro Tokorodani, Toshiaki Kume, Hiromitu Daisaki, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32975-e32975
Open Access | Times Cited: 7
Serum α-SMA is a potential noninvasive biomarker of liver fibrosis
Irina Cardoso-Lezama, Erika Ramos‐Tovar, Jaime Arellanes‐Robledo, et al.
Toxicology Mechanisms and Methods (2023) Vol. 34, Iss. 1, pp. 13-19
Closed Access | Times Cited: 7
Suboptimal reliability of FIB‐4 and NAFLD‐fibrosis scores for staging of liver fibrosis in general population
Rawi Hazzan, Nur Abu Ahmad, Abu Shqara Habib, et al.
JGH Open (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top